To characterize the importance of infection of epithelial cells for morbillivirus pathogenesis, we took advantage of the severe disease caused by canine distemper virus (CDV) in ferrets. To obtain a CDV that was unable to enter epithelial cells but retained the ability to enter immune cells, we transferred to its attachment (H) protein two mutations shown to interfere with the interaction of measles virus H with its epithelial receptor, human nectin-4. As expected for an epithelial receptor (EpR)-blind CDV, this virus infected dog and ferret epithelial cells inefficiently and did not cause cell fusion or syncytium formation. On the other hand, the EpR-blind CDV replicated in cells expressing canine signaling lymphocyte activation molecule (SLAM), the morbillivirus immune cell receptor, with similar kinetics to those of wild-type CDV. While ferrets infected with wild-type CDV died within 12 days after infection, after developing severe rash and fever, animals infected with the EpR-blind virus showed no clinical signs of disease. Nevertheless, both viruses spread rapidly and efficiently in immune cells, causing similar levels of leukopenia and inhibition of lymphocyte proliferation activity, two indicators of morbillivirus immunosuppression. Infection was documented for airway epithelia of ferrets infected with wild-type CDV but not for those of animals infected with the EpR-blind virus, and only animals infected with wild-type CDV shed virus. Thus, epithelial cell infection is necessary for clinical disease and efficient virus shedding but not for immunosuppression.
M
orbilliviruses are highly contagious and can cause severe disease in their respective hosts. Measles virus (MeV), which infects humans and certain nonhuman primates, is generally associated with mild to moderate clinical signs (5) , while the closely related Canine distemper virus (CDV) infects a broad range of carnivores and causes severe and frequently lethal disease (2) . Upon aerosol transmission, these viruses initially target signaling lymphocyte activation molecule (SLAM; CD150)-expressing immune cells in the respiratory tract (6, 11) , followed by dissemination throughout the lymphatic system (4, 33) . SLAM proteins from different host species serve as receptors for multiple morbilliviruses (31) , and the amino acid residues involved in the interaction of the MeV and CDV attachment (H) proteins with SLAM are structurally conserved (32, 34) . The importance of immune cell targeting for the establishment of morbillivirus infection is illustrated by the complete attenuation of SLAM-bindingdefective MeV and CDV in vivo, despite their ability to infect and replicate in nonimmune cells as efficiently as wild-type viruses in vitro (12, 36) .
In contrast, the role of epithelial cell tropism in morbillivirus pathogenesis is less clear. Infection of epithelia coincides with the development of the characteristic rash and respiratory and gastrointestinal signs of disease, and the extent of dissemination correlates with the severity of clinical signs (15, 33) . MeV H protein residues critical for infection of epithelial cells have been identified (13, 29) , and these residues are important for binding to nectin-4, the recently identified MeV epithelial receptor (17, 19) . Pathogenesis of a nectin-4-blind MeV in rhesus macaques was similar to that of the parental wild-type strain, although no virus shedding into the airways was observed (13) . However, since MeV-induced disease in monkeys was generally mild and short-lived, it was difficult to assess how relevant infection of epithelial tissues is for disease and pathogenesis.
Because of the more severe disease caused by CDV in ferrets, this animal model is ideal for characterizing morbillivirus pathogenesis mechanisms (24) . A recent study demonstrated that several of the amino acids that are involved in nectin-4 binding of MeV H are also important for CDV epithelial cell entry (10, 13) , indicating that similar to immune cell entry via SLAM, the mechanism of epithelial cell infection may be conserved among morbilliviruses. We therefore transferred mutations conferring the nectin-4-blind phenotype to MeV H into the H protein of a lethal CDV strain. After in vitro characterization of the mutant H proteins, we generated a candidate epithelial receptor (EpR)-blind virus and confirmed that it was unable to infect canine and ferret epithelial cells. The pathogenesis and tropism of this virus were then characterized in ferrets.
MATERIALS AND METHODS

Cells and transfections.
Vero cells constitutively expressing canine SLAM (VerodogSLAMtag cells) (35) , 293 cells (ATCC CRL-1573), MadinDarby canine kidney (MDCK) cells (ATCC CCL-34), and ferret alveolar epithelial cells (FtAEpCs) (9) were maintained in Dulbecco's modified Eagle medium (DMEM; Gibco) supplemented with 5% heat-inactivated fetal bovine serum (FBS). For the biochemical analysis of recombinant proteins, 12-well plates of VerodogSLAMtag cells were transfected at ap-proximately 90% confluence as described previously (26, 27) . Briefly, each well was transfected with 2 g each of the H expression plasmid pCG-H5804Pzeo (34) or the respective mutant H plasmid and a plasmid expressing either the MeV Edmonston (3) or CDV 5804P F protein by use of Turbofect (Fermentas). Fusion activity was evaluated after 24 h. Alternatively, cells were lysed in 200 l of RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-40, and 0.5% sodium deoxycholate) containing a protease inhibitor cocktail (Complete; Roche) 16 h after transfection. The lysate was centrifuged at 14,000 rpm for 15 min at 4°C and stored at Ϫ20°C.
Production of EpR/nectin-4-blind CDV and MeV H proteins. To generate EpR-blind CDV H proteins, site-directed mutagenesis was performed on the plasmid pCG-H5804PZeo (34) to introduce the mutations V478S, P493S, and Y539A, as well as the double mutation P493S/Y539A. These mutations correspond to those reported by Leonard et al. (13) , taking into account the four additional amino acids present upstream of that region in MeV H (34) . The nectin-4-blind MeV H protein expression plasmids for the L482S, P497S, Y543A, and P497S/Y543A mutants were generated by site-directed mutagenesis of the plasmid pcDNA3.1-MeV H IC323 (13, 30) .
To generate the recombinant virus p5804PeH EpR-blind , the P497S/ Y543A double mutation was first introduced into a subgenomic plasmid containing the region between the BsrGI and AscI restriction sites. Using these restriction sites, the fragment was then transferred into the full-length p5804PeH plasmid, which expresses enhanced green fluorescent protein (EGFP) from an additional open reading frame located between the H and polymerase genes (33) . All plasmids were verified by sequencing.
Recovery of recombinant virus and growth kinetics. The recombinant EpR-blind CDV was recovered by transfecting semiconfluent 293 cells with 6 g of p5804PeH EpR-blind and a combination of 0.5, 0.1, 0.5, and 0.7 g MeV N, P, and polymerase (L) and T7 RNA polymerase expression plasmids (1, 14) , respectively, using Turbofect (Fermentas). Three days later, the transfected cells were transferred onto VerodogSLAMtag cells seeded at 80 to 90% confluence in 10-cm dishes. Individual syncytia were inoculated on fresh VerodogSLAMtag cells. Stocks of all viruses used in this study were produced on VerodogSLAMtag cells. Titers were determined by limiting dilution and expressed as 50% tissue culture infective doses (TCID 50 ).
For growth kinetics, VerodogSLAMtag and MDCK cells and FtAEpCs were plated in 24-well plates and infected at a multiplicity of infection (MOI) of 0.1 or 0.01. For VerodogSLAMtag cells, cells were scraped into the supernatant and harvested daily for 4 days; for MDCK cells and FtAEpCs, samples were harvested every second day for 8 days. Titers were determined by a limiting dilution method and expressed as TCID 50 . Phase-contrast and fluorescence pictures were taken on the days of harvest.
Cell surface biotinylation and Western blot analysis. For cell surface biotinylation, transfected cells were incubated for 20 min at 4°C with EZ-Link N-hydroxysuccinimide (NHS)-LC-LC-biotin (Pierce) at a concentration of 2 mM in phosphate-buffered saline (PBS) and then washed with 100 mM glycine in PBS (Invitrogen) to quench excess biotin. The cells were then lysed with RIPA buffer with protease inhibitors, and a 20-l aliquot of each sample was mixed directly with an equal volume of 2ϫ SDS gel loading buffer (SDS-GLB) containing 10% ␤-mercaptoethanol and stored at Ϫ20°C. The remaining lysate was mixed with immobilized protein G Plus beads (Santa Cruz) and a rabbit anti-peptide antiserum raised against the cytoplasmic tail (Hcyt) of the respective H protein (37) . After agitation overnight at 4°C, samples were washed three times, mixed with 1ϫ SDS-GLB, and heated at 75°C for 5 min. The immunoprecipitated proteins were separated in parallel in SDS-PAGE gels and transferred to polyvinylidene difluoride (PVDF) membranes. Total cellular expression of recombinant H proteins was detected using the respective Hcyt antiserum in combination with a horseradish peroxidase (HRP)-labeled secondary antiserum, while biotinylated proteins were detected using a streptavidin-HRP conjugate (Pierce) and visualized using an ECL ϩ chemiluminescence kit (GE Healthcare). Bands were quantified using Molecular Imaging software (Kodak).
In vivo characterization of recombinant viruses. Ferrets (Mustela putoris furo) aged 16 weeks and older (Marshall Farms) and lacking antibodies against CDV were used for all studies. All animal experiments were approved by the Animal Care and Use Committee of the INRSInstitut Armand-Frappier. Groups of five or eight ferrets were infected intranasally with 10 5 TCID 50 of the parental strain 5804PeH or strain 5804PeH EpR-blind , respectively. Body temperature and clinical signs were recorded daily and scored based on a scale of 0 to 2, with 0 representing no change, 1 representing moderate disease, and 2 representing severe disease. Blood samples were collected from the jugular veins of animals under general anesthesia twice weekly for the first 2 weeks and weekly thereafter. Cell-associated viremia in peripheral blood mononuclear cells (PBMC) was quantified by a limiting dilution method (36) , and the percentage of EGFP-expressing cells was determined by flow cytometry. The extent of PBMC proliferation inhibition was assessed by stimulation of Ficoll-purified PBMC with 1 g/ml phytohemagglutinin (PHA) and subsequent detection of bromodeoxyuridine (BrdU) incorporation into proliferating cells by use of a cell proliferation BrdU enzyme-linked immunosorbent assay (ELISA) kit (Roche). Wild-type virus infection results include previously published data obtained from three animals (27) . Two animals of each group were sacrificed on day 7 postinfection, and three were sacrificed on day 12 postinfection, to assess dissemination and to harvest tissues for histological analysis. On day 12, throat swabs were collected in 0.5 ml Opti-MEM (Invitrogen) with double-concentrated penicillin and streptomycin (Invitrogen), and urine was collected aseptically from the bladder with a needle and syringe. Virus titers were quantified by a limiting dilution method and expressed as TCID 50 /ml.
Immunohistochemistry of ferret tissues. For immunohistochemistry staining, paraffin sections were deparaffinized and rehydrated following standard immunohistochemistry protocols. Endogenous peroxidase was quenched with 0.3% H 2 O 2 in PBS for 12 min. After blocking with a 1:50 dilution of goat serum in PBS, the primary anti-CDV N monoclonal antibody (CDV-NP; VMRD) was added for 1 h at room temperature, followed successively by a biotinylated goat anti-mouse secondary antibody and a peroxidase-labeled streptavidin conjugate (Vector Laboratories) for 45 min each at room temperature. Infected cells were visualized using 3,3=-diaminobenzidine (DAB) substrate (Sigma), and slides were counterstained with hematoxylin.
For the detection of different cell types, cryosections of paraformaldehyde-fixed OCT-embedded tissues were thawed, permeabilized with 0.1% Triton X-100 in PBS for 10 min, and blocked with 1:50-diluted goat serum in PBS for 30 min. The slides were then incubated with either a CD3 (sc-20047; Santa Cruz) or pan-cytokeratin (C2562; Sigma) antibody for 1 h, followed by a goat anti-mouse Alexa Fluor 568-labeled secondary antiserum (Invitrogen). The slides were counterstained with 4=,6-diamidino-2-phenylindole (DAPI; Invitrogen) and mounted in Vectamount (Vector Laboratories).
RESULTS
The CDV H P493S/Y539A double mutant is EpR blind while retaining wild-type SLAM-mediated fusion efficacy. To generate an EpR-blind CDV, the MeV IC323 and CDV 5804P H proteins were aligned, and the V478S, P493S, and Y539A mutations, which correspond to the L482S, P497S, and Y543A mutations that confer the nectin-4-blind phenotype in MeV H (13), were introduced into a CDV H expression plasmid (Fig. 1A) . Two of these positions, V478 and Y539, were recently identified independently as relevant to EpR in a CDV H protein alanine scanning mutagenesis study (10) , thereby validating our approach. Alteration of position 493 resulted in a 70% reduction of surface expression (Fig.  1B) as detected by cell surface biotinylation. A similar reduction in surface expression was observed for the corresponding MeV P497S mutant (Fig. 1C) , as well as the CDV and MeV H proteins carrying double mutations (P493S/Y539A for CDV H and P497S/ Y543A for MeV H) (Fig. 1B and C) , indicating that the proline residue at position 493/497 is important for H protein transport.
However, none of the mutations significantly affected the level of cell-to-cell fusion in VerodogSLAMtag cells when the respective H proteins were coexpressed with either the MeV Edmonston (3) or CDV 5804P fusion (F) protein (Fig. 1D) .
Since none of the carnivore epithelial cell lines used for the visualization of infected cells. While each of the individual mutations resulted in a reduction of epithelial cell infection efficiency (data not shown), only the double mutant previously identified in the MeV system was unable to infect epithelial cells and was thus chosen for further characterization. The wild-type and 5804PeH EpR-blind viruses replicated to similar maximum titers in VerodogSLAMtag cells ( Fig. 2A, left panel) . Both viruses induced the formation of syncytia of comparable sizes (Fig. 2C) , illustrating that the reduced cell surface expression associated with the P497S mutation did not affect fusion efficiency or overall viability in the context of SLAM-mediated infection. In contrast, only the wild-type virus replicated efficiently in MDCK cells and FtAEpCs ( Fig. 2A and B) . Even at a 10-fold-higher MOI, 5804PeH EpR-blind resulted in only a few infected foci and in titers slightly above the detection level at some of the time points (Fig.  2B, D, and E) . Thus, the transfer of the mutations involved in MeV interaction with nectin-4 to CDV resulted in the expected EpRblind phenotype.
5804PeH EpR-blind causes severe immunosuppression but no clinical disease. To assess the importance of spread to epithelial tissues for morbillivirus pathogenesis, ferrets were infected intranasally with 10 5 TCID 50 of the parental strain 5084PeH or strain 5804PeH EpR-blind . In contrast to the case with 5804PeH-infected animals, which developed severe rash and fever and died within 12 days after infection, the EpR-blind virus did not elicit fever and caused no clinical signs of disease (Fig. 3A and B) . Fluorescence imaging revealed a few weakly GFP-expressing spots around the mouths and eyes as the only indication of 5804PeH EpR-blind infection, while the wild-type virus resulted in extensive fluorescence of all mucosal surfaces and caused the typical skin rash (33; data not shown). Despite these differences in pathogenesis, both viruses resulted in similar kinetics of cell-associated viremia (Fig. 3C) , with 70 to 90% of PBMC infected 7 days after inoculation (Fig.  3D) , indicating that the epithelial cell receptor-blind virus was not affected in the ability to infect immune cells and spread throughout the lymphatic system. All animals also developed strong leukopenia, resulting in an 80% reduction in leukocytes at day 10 after infection (Fig. 3E) . Finally, infection with both viruses resulted in a 75% inhibition of lymphocyte proliferation activity (Fig. 3F) . Thus, the values of these two indicators of morbillivirus immunosuppression (7, 24) were equivalent for the first 10 days of infection. Even though recovery of the white blood cell count and lymphocyte proliferation activity in 5804PeH EpR-blind -infected animals correlated to a certain extent with virus clearance, preinfection levels were not reached during the duration of the experiment.
To investigate the importance of epithelial cell infection for shedding, three additional animals were infected with each virus, and throat swabs and urines were collected on day 12 after infection. While high titers were detected in samples from wild-type virusinfected animals, no virus was found in samples from the EpR-blind virus group (Fig. 3G) . Thus, the EpR-blind CDV remained immunosuppressive but did not cause disease and was not shed.
5804PeH EpR-blind is not detected in epithelial tissues. Immunohistochemical staining of paraformaldehyde-fixed paraffinembedded tissue sections from animals sacrificed on day 7 or 12 after infection, using a CDV nucleoprotein-specific monoclonal antibody, revealed similar infection levels in the intestinal lymph nodes (Fig. 4A to D) and other immune tissues (data not shown). In contrast, CDV-positive epithelial cells were found only in tissues from animals infected with wild-type virus ( Fig. 4E to P) , with infection levels increasing over time. Occasional infected cells detected in epithelial tissues of EpR-blind virus-infected animals were all of lymphoid morphology (Fig. 4J and L, arrows) , and staining of paraformaldehyde-fixed cryosections (which maintained EGFP expression in infected cells) with antibodies for T cells or epithelial cells confirmed that most infected cells were indeed immune cells (Fig. 5) . Taken together, these results suggest that infection of epithelial tissues is essential for clinical disease and shedding but has minimal, if any, influence on immunosuppression.
DISCUSSION
After transmission by aerosol, morbilliviruses cross the respiratory epithelium to reach immune tissues via infected immune cells, most likely macrophages or dendritic cells (6, 11, 13, 33) . Nevertheless, since it is conceivable that epithelial cell infection sustains virulence in late infection stages, we sought to confer an EpR-blind phenotype to an extremely virulent CDV strain that is lethal for ferrets. To this end, we transferred the MeV H P497S/ Y543A double mutation, which results in a nectin-4-blind MeV (13, 17) , into the CDV 5804PeH H protein. The resulting recombinant virus efficiently infected and replicated in SLAMexpressing Vero cells but was severely impaired in the ability to infect canine or ferret epithelial cell lines. In ferrets, the EpR-blind CDV was initially indistinguishable from the wild-type virus, reaching similar infection levels and causing severe leukopenia and inhibition of lymphocyte proliferation. However, the virus was completely attenuated, and there was no shedding. Immunohistochemistry staining confirmed the EpR-blind phenotype in vivo, indicating that epithelial cell infection is critical for clinical morbillivirus disease.
Immune cell infection alone is sufficient to induce prolonged immunosuppression. Severe acute and, in many cases, longlasting immunosuppression is a hallmark of morbillivirus infections (7) . During the acute phase, morbillivirus immunosuppression is characterized by an often dramatic leukopenia and an inability of PBMC to proliferate upon stimulation (18, 25, 28) , and the extent of both parameters correlates with disease severity (21, 28, 38) . However, while leukocyte counts recover rapidly after virus clearance (16, 22) , the inhibition of lymphocyte proliferation frequently persists beyond clinical recovery (8, 38) . The wildtype levels of leukopenia and inhibition of lymphocyte proliferation we saw in animals infected with the EpR-blind virus now demonstrate that acute immunosuppression is primarily a consequence of immune cell infection and can occur independently from clinical disease. Our findings are supported by the leukopenia and inhibition of lymphocyte proliferation observed in knock-in mice expressing murine SLAM with a human V domain (20) , which carries the MeV H-interacting residues (23), since MeV is de facto EpR blind in these animals due to the lack of appropriate receptors in cells other than the SLAM-expressing immune cells. The prolonged inhibition of lymphocyte proliferation activity in the absence of clinical disease in ferrets infected with the EpR-blind CDV further suggests that this virus provides a unique opportunity to investigate mechanisms underlying prolonged morbillivirus immunosuppression and its impact on susceptibility to secondary infections.
Epithelial cell infection is not required for initial infection and dissemination but is essential for clinical disease and shedding. Consistent with a previous report of a nectin-4-blind MeV reaching wild-type titers in PBMC from infected rhesus monkeys (13) , the EpR-blind CDV replicated with wild-type kinetics in ferret PBMC and attained similar infection levels. Taken together with the lack of viremia and disease progression associated with SLAM-blind viruses (12, 36) , these results further illustrate that epithelial cell infection plays little to no role in the initial stages of morbillivirus pathogenesis.
In wild-type and nectin-4-blind MeV-infected rhesus macaques, similar rash frequencies and severities, but no other clinical signs, were reported (13) . In contrast, we observed only a few EGFP-expressing spots at the lips and eyes of ferrets infected with the EpR-blind virus, while the wild-type virus was associated with severe rash. Since studies with EGFP-expressing MeV in cynomolgus macaques demonstrated that the rash represents infected immune cells in the skin rather than infected skin cells (4), the occasionally observed EGFP-positive foci in EpR-blind virus-infected ferrets may thus likely be attributed to immune cell infection, while the more severe manifestation seen in wild-type virusinfected animals reflects spread to epithelial skin cells. We previously reported a correlation between the onset of rash and clinical signs and the spread to epithelial tissues (33) , and septicemia due to disruption of epithelial barriers in the intestine has long been considered the most likely immediate cause of death for CDVinfected ferrets. The results presented here clearly establish epithelial cell infection as the cause of clinical disease by CDV and, likely, by morbilliviruses in general. Furthermore, the absence of virus in tracheal aspirates of monkeys (13) and throat swabs and urines of ferrets infected with EpR-blind viruses suggests that epithelial cell infection is necessary for shedding and ultimate spread to new hosts. Therapeutic interventions that aim to interrupt the dissemination to epithelial tissues may thus not only protect from clinical disease but also prevent transmission.
Morbillivirus H protein residues important for epithelial cell infection are conserved. Epithelial cell infection is an integral part, to various extents, of morbillivirus pathogenesis (7). Several of the MeV H protein amino acids involved in binding to the recently discovered epithelial cell receptor nectin-4 (13, 17, 19, 29) were found to also be essential for CDV epithelial cell infection in an independent alanine scanning mutagenesis study of the corresponding CDV H protein region (10) . Here we show that introduction of the two key mutations into the H protein of a wild-type CDV strain resulted in an EpR-blind phenotype in vitro and in vivo. While the role of nectin-4 as a receptor for CDV remains to be demonstrated, the involvement of the same H protein residues in MeV and CDV epithelial cell infections strongly suggests that the epithelial cell receptor, similar to the immune cell receptor SLAM (31) , is conserved among morbilliviruses.
